A carregar...

Cisplatin/carboplatin cross-resistance in ovarian cancer.

Forty-six patients who were treated with cisplatin or carboplatin for ovarian cancer developed resistant disease (no change in measurable disease or progressive disease) and 'crossed over' to the other platinum compound. Three patients (6.5%) responded to this second treatment but these pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gore, M. E., Fryatt, I., Wiltshaw, E., Dawson, T., Robinson, B. A., Calvert, A. H.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1989
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2247292/
https://ncbi.nlm.nih.gov/pubmed/2803953
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!